Rituximab Chimeric Monoclonal Antibody
Rituximabis a research-grade recombinant antibody targeting CD20. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 1, MS4A1, Leukocyte surface antigen Leu-16, B-lymphocyte antigen CD20, Bp35, CD20
UniProt
P11836
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Chimeric
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-kappa
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6441430-01 0.1 mL
TPH1 (Tryptophan Hydroxylase 1, Tryptophan 5-hydroxylase 1, MGC119994, TPRH, TRPH) (MaxLight 550)
Sign In for Pricing
View Details MBS6441430-02 5x 0.1 mL
TPH1 (Tryptophan Hydroxylase 1, Tryptophan 5-hydroxylase 1, MGC119994, TPRH, TRPH) (MaxLight 550)
Sign In for Pricing
View Details 
MBS6469265-01 0.2 mL
CLDN2, Phosphorylated (Tyr224) (Claudin-2, SP82, PSEC0059, SP82, UNQ705/PRO1356) (Biotin)
Sign In for Pricing
View Details